International Journal of Drug Delivery Technology
Volume 15, Issue 3

Optimization of Beta Sitosterol Phytosome Formulation using Box Behnken Design for Enhanced Bioavailability

Srikala Kamireddy, Shanmuga Sundaram Sangeetha* 

Department of Pharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur-603203, Tamil Nadu, India 

Received: 18th Jul, 2025; Revised: 1st Sep, 2025; Accepted: 8th Sep, 2025; Available Online: 25th Sep, 2025 

ABSTRACT

Beta-sitosterol, a plant-derived phytosterol, holds promise as an anti-obesity medication. However, its limited bioavailability and low aqueous solubility hinder its therapeutic application. This research aimed to utilize phytosome technology, developed and optimized using Box-Behnken Design (BBD), to enhance the bioavailability of beta-sitosterol. L-α-phosphatidylcholine was used as the lipid carrier in the thin-film hydration process to create phytosomes. Entrapment efficiency (EE%), particle size, zeta potential, and polydispersity index (PDI) were the four dependent responses, and the effects of three independent variables, such as molar ratio, reaction time, and temperature, were systematically assessed. The improved formulation demonstrated robust drug encapsulation, nanoscale size, good colloidal stability, and uniformity with an entrapment efficiency of 86.41%, particle size of 163.53nm, zeta potential of -30.06mV, and Poly dispersity index of 0.2148. When compared to the pure drug, in vitro drug release experiments showed a noticeable, improved and prolonged release profile of beta-sitosterol from the phytosomal formulation. The ideal formulation parameters, determined at a molar ratio of 2:1, a time taken for the reaction of 74.79 minutes at an operating temperature of 38.260C and they were validated by overlay plot analysis. These results demonstrate the potential of this phytosomal strategy to enhance the administration of poorly soluble phytoconstituents, including beta-sitosterol, for anti-obesity treatment and validate the effective use of BBD in modifying phytosomal formulations.

Keywords: Zeta Potential, Entrapment Efficiency, Beta-sitosterol, Phytosome, Box-Behnken Design, Bioavailability, Obesity.

How to cite this article: Srikala Kamireddy, Shanmuga Sundaram Sangeetha. Optimization of Beta Sitosterol Phytosome Formulation using Box Behnken Design for Enhanced Bioavailability. International Journal of Drug Delivery Technology. 2025;15(3):1022-27. doi: 10.25258/ijddt.15.3.17

REFERENCES

  1. Mohajan D, Mohajan HK. Body mass index (BMI) is a popular anthropometric tool to measure obesity among adults. Journal of Innovations in Medical Research. 2023 May 5;2(4):25-33.
  2. Awuchi CG, Igwe VS, Amagwula IO. Nutritional diseases and nutrient toxicities: A systematic review of the diets and nutrition for prevention and treatment. International Journal of Advanced Academic Research. 2020 Jan;6(1):1-46.
  3. Rinonapoli G, Pace V, Ruggiero C, Ceccarini P, Bisaccia M, Meccariello L, Caraffa A. Obesity and bone: a complex relationship. International journal of molecular sciences. 2021 Dec 20;22(24):13662.
  4. Krzysztoszek J, Laudanska-Krzeminska I, Bronikowski M. Assessment of epidemiological obesity among adults in EU countries. Annals of Agricultural and Environmental Medicine. 2019;26(2).
  5. Ahmed B, Konje JC. The epidemiology of obesity in reproduction. Best Practice & Research Clinical Obstetrics &Gynaecology. 2023 Jul 1;89:102342.
  6. Güngör NK. Overweight and obesity in children and adolescents. Journal of clinical research in pediatric endocrinology. 2014 Sep 5;6(3):129.
  7. Aronne LJ. Classification of obesity and assessment of obesity‐related health risks. Obesity research. 2002 Dec;10(S12):105S-15S.
  8. Salam MM, Yousuf R, Salam MW, Haque M. Obesity and overweight: A global public health issue. Advances in Human Biology. 2023 Jan 1;13(1):154-6.
  9. Phelps NH, Singleton RK, Zhou B, Heap RA, Mishra A, Bennett JE, Paciorek CJ, Lhoste VP, Carrillo-Larco RM, Stevens GA, Rodriguez-Martinez A. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. The Lancet. 2024 Mar 16;403(10431):1027-50.
  10. Lim HJ, Xue H, Wang Y. Global trends in obesity. Handbook of Eating and Drinking: Interdisciplinary Perspectives. 2020:1217-35.
  11. Mohajan D, Mohajan HK. Obesity and its related diseases: a new escalating alarming in global health. Journal of Innovations in Medical Research. 2023 Mar 23;2(3):12-23.
  12. Parikh NI, Pencina MJ, Wang TJ, Lanier KJ, Fox CS, D’Agostino RB, Vasan RS. Increasing trends in incidence of overweight and obesity over 5 decades. The American journal of medicine. 2007 Mar 1;120(3):242-50.
  13. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. Jama. 2010 Jan 20;303(3):235-41.
  14. Khan S. Risk factors of periodontitis in Australian adults(Doctoral dissertation, University of Tasmania).
  15. Jaacks LM, Vandevijvere S, Pan A, McGowan CJ, Wallace C, Imamura F, Mozaffarian D, Swinburn B, Ezzati M. The obesity transition: stages of the global epidemic. The lancet Diabetes & endocrinology. 2019 Mar 1;7(3):231-40.
  16. Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, Yang H, Liu C, Kam LY, Tan XX, Chien N. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. The lancet Gastroenterology & hepatology. 2020 Aug 1;5(8):739-52.
  17. Khan Z, Nath N, Rauf A, Emran TB, Mitra S, Islam F, Chandran D, Barua J, Khandaker MU, Idris AM, Wilairatana P. Multifunctional roles and pharmacological potential of β-sitosterol: Emerging evidence toward clinical applications. Chemico-biological interactions. 2022 Sep 25;365:110117.
  18. Abo-Zaid OA, Moawed FS, Ismail ES, Farrag MA. β-sitosterol attenuates high-fat diet-induced hepatic steatosis in rats by modulating lipid metabolism, inflammation and ER stress pathway. BMC Pharmacology and Toxicology. 2023 May 12;24
  19. Ding J, Zhang R, Ahmed S, Liu Y, Qin W. Effect of sonication duration in the performance of polyvinyl alcohol/chitosan bilayer films and their effect on strawberry preservation. Molecules. 2019 Apr 10;24(7):1408.
  20. Tai K, Rappolt M, He X, Wei Y, Zhu S, Zhang J, Mao L, Gao Y, Yuan F. Effect of β-sitosterol on the curcumin-loaded liposomes: Vesicle characteristics, physicochemical stability, in vitro release
  21. Lv Y, He H, Qi J, Lu Y, Zhao W, Dong X, Wu W. Visual validation of the measurement of entrapment efficiency of drug nanocarriers. International journal of pharmaceutics. 2018 Aug 25;547(1-2):395-403.
  22. Pandey R, Patil PO, Patil MU, Deshmukh PK, Bari SB. Quantitative estimation of diacerein in bulk and in capsule formulation using hydrotropic solubilizing agents by UV-spectrophotometry and the first order derivative using the area under curve method. Pharmaceutical methods. 2012 Jan 1;3(1):4-8.
  23. Alhalmi A, Amin S, Beg S, Al-Salahi R, Mir SR, Kohli K. Formulation and optimization of naringin loaded nanostructured lipid carriers using Box-Behnken based design: In vitro and ex vivo Journal of Drug Delivery Science and Technology. 2022 Aug 1;74:103590.
  24. Moolakkadath T, Aqil M, Ahad A, Imam SS, Praveen A, Sultana Y, Mujeeb M. Preparation and optimization of fisetin loaded glycerol based soft nanovesicles by Box-Behnken design. International journal of pharmaceutics. 2020 Mar 30;578:119125.
  25. Sharma M, Sharma G, Singh B, Katare OP. Systematically optimized imiquimod-loaded novel hybrid vesicles by employing design of experiment (DoE) approach with improved biocompatibility, stability, and dermato kinetic profile. AAPS PharmSciTech. 2019 May;20:1-4.
  26. Brito Raj S, Chandrasekhar KB, Bhaskar Reddy K. Design, development and in vivo pharmacokinetic evaluation of cardiovascular drug‑loaded nanostructured lipid carrier system. Int J Drug Deliv Technol. 2018 Jul–Sep;7(3):190–209.
  27. Senthamarai R, Thota S. Carvacrol‑Loaded Phytosomes for Enhanced Wound Healing: Molecular Docking, Formulation, DoE‑Aided Optimization, and in vitro/in vivo Evaluation. Int J Nanomedicine. 2023 Dec 31;18:5749–60. doi:10.2147/IJN.S123456.
  28. Kamireddy S, Sangeetha S, Roy H. An approach to development and in‑vivo evaluation of beta‑sitosterol phytosomes by Taguchi orthogonal array design. Int J Drug Deliv Technol. 2024 Jul;14(3).